Asymchem (06821) to Repurchase and Cancel 0.06 Million Restricted A Shares After Staff Resignations

Bulletin Express03-13 21:01

Hong Kong, 13 March 2026—Asymchem Laboratories (Tianjin) Co., Ltd. (Stock Code: 06821) has approved the repurchase and cancellation of 0.06 million restricted A shares originally granted under its 2025 A Share Restricted Share Incentive Scheme.

The move follows the resignation of five incentive participants—four from the initial grant and one from the reserved grant—who no longer meet scheme eligibility requirements.

Key transaction details: • Shares involved: 61,000 restricted A shares (56,000 from the initial grant; 5,000 from the reserved grant). • Repurchase prices: RMB36.42 per share for the initial grant and RMB53.24 per share for the reserved grant. • Total consideration: RMB2.31 million, to be funded entirely from internal resources.

Share capital impact: • A shares will decrease from 333.01 million to 332.95 million. • Total issued shares will fall from 360.84 million to 360.78 million. • A-share weighting will edge down to 92.28%, while H-share weighting will rise slightly to 7.72%.

Management stated that the adjustment will not materially affect the company’s financial position or its 2025 earnings, and the broader incentive scheme remains in force.

The repurchase and cancellation require shareholder approval; a circular with full details will be dispatched in due course.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment